Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial | LANCET HAEMATOLOGY |